Cardiomyopathy Trial, Recruiting (NCT06332859)

Cardiomyopathy Trial, Recruiting NCT06332859 Sponsor: Pensionsversicherungsanstalt Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06332859 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Takotsubo cardiomyopathy (sometimes called "broken heart syndrome") or have had a heart attack within the last 6 months
You are older than 18 years of age
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

You are currently experiencing an acute illness (such as an infection or other sudden health problem) that has lasted more than 3 days
You do not have a sufficient understanding of German to be able to take part in the resilience training sessions (this will be assessed by the person recruiting you to the trial)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Doreen Stöhr, Mag., Austrian Pension Insurance Institution

Phone: 0043 50303 26710

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06332859

Sponsor: Pensionsversicherungsanstalt

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: 0043 50303 26710

More information: https://clinicaltrials.gov/study/NCT06332859

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Takotsubo cardiomyopathy (sometimes called "broken heart syndrome") or have had a heart attack within the last 6 months
You are older than 18 years of age
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

You are currently experiencing an acute illness (such as an infection or other sudden health problem) that has lasted more than 3 days
You do not have a sufficient understanding of German to be able to take part in the resilience training sessions (this will be assessed by the person recruiting you to the trial)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Pensionsversicherungsanstalt

Registry

ClinicalTrials.gov

Start date

15 April 2024

Est. completion

14 October 2026

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Resilience scale-13 (RS-13); Brief Resilience scale - German Version (BRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov